AMN
AIIMS, Delhi has started the registration process for conducting the human trials of COVAXIN, today.
Principal Investigator for conducting these trials at one of the top medical institutes in the country, AIIMS Delhi , Dr.
Sanjay Rai has said that the response for registration has been overwhelming.
Dr. Rai told media that the first dose of the vaccine is likely to be administered to the volunteers on this Thursday.